June 12, 2023 02:47 PM EDT
Startups
Pharma

Once promis­ing can­cer ther­a­py start­up On­corus ad­mits de­feat af­ter lay­ing off most of its staff

Katherine Lewin

News Reporter

Mass­a­chu­setts-based On­corus fi­nal­ly hit the end of the road, join­ing the slate of biotechs shut­ting down pro­grams and lay­ing off staff. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Mer­ck CEO says Keytru­da is ‘not a re­peat­able mod­el’

Neu­ro­crine CEO Kevin Gor­man to re­tire af­ter 32-year run; Blue­bird picks up fifth CFO in three years

Joe Jimenez and Mark Fish­man tar­get $400M for third fund af­ter leav­ing No­var­tis

FDA ques­tions da­ta on MD­MA-based ther­a­py in PTSD ahead of ad­vi­so­ry com­mit­tee

Joe Panet­ta to step down as Bio­com Cal­i­for­nia CEO

sponsored

A nov­el study in­sight an­a­lyt­ics (SIA) method­ol­o­gy im­proves PANSS da­ta qual­i­ty and sig­nal de­tec­tion in a glob­al ...

A service from the Financial Times